Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,568 shares at $215.58 ($1.6M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
Open-market sale of $1.6M VRTX by EVP, Chief Patient Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $215.58 | 2,346 | $506K | 30.9% |
| 2 | $215.58 | 2,346 | $506K | 30.9% |
| 3 | $216.67 | 1,338 | $290K | 17.7% |
| 4 | $216.67 | 1,338 | $290K | 17.7% |
| 5 | $217.69 | 200 | $44K | 2.7% |
| Total | $216.02 avg | 7,568 |
| $1.6M |
| 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |